Scientists Reverse Memory Loss in Dementia Mice by Recharging Brain Cells

Researchers are increasingly exploring whether memory loss in diseases such as Alzheimer’s may begin long before brain cells die. A new study suggests that the problem could start with mitochondria — tiny structures inside cells that generate energy.

In research published in Nature Neuroscience, scientists from Inserm, University of Bordeaux, and Université de Moncton demonstrated for the first time a direct cause-and-effect link between faulty mitochondrial activity and cognitive decline linked to neurodegenerative disease.

Their findings suggest that neurons may lose energy and malfunction before they die, potentially opening a new direction for dementia treatment research.

What exactly are mitochondria and why do they matter in the brain?

Mitochondria are microscopic structures inside cells that act as energy generators. They produce the power cells need to function normally.

This is especially important in the brain because neurons consume enormous amounts of energy to communicate with one another. If mitochondrial activity drops, neurons may struggle to send signals efficiently, weakening memory and thinking processes over time.

Scientists have long observed mitochondrial problems in Alzheimer’s disease and other neurodegenerative disorders. However, researchers were unsure whether those problems caused the disease or simply appeared after brain damage had already begun.

The new study aimed to answer that question directly.

How did scientists test whether mitochondrial failure causes memory loss?

The research team developed a highly specific experimental tool that could temporarily increase mitochondrial activity in the brain.

Earlier research had already identified that G proteins — molecules involved in transferring information within cells — help regulate mitochondrial activity. Building on that work, researchers engineered an artificial receptor called mitoDreadd-Gs.

The receptor was designed to activate G proteins directly inside mitochondria, boosting their activity and restoring energy production in neurons.

When scientists activated mitoDreadd-Gs in mouse models of dementia, mitochondrial function returned to normal levels. Remarkably, memory performance also improved.

The findings suggest that mitochondrial dysfunction may actively contribute to cognitive decline instead of simply accompanying it.

Why is this discovery considered significant for Alzheimer’s research?

The study challenges the traditional view that memory loss is mainly driven by irreversible neuron death.

Instead, it suggests some neurons involved in dementia may still be alive but operating with insufficient energy.

“This work is the first to establish a cause-and-effect link between mitochondrial dysfunction and symptoms related to neurodegenerative diseases, suggesting that impaired mitochondrial activity could be at the origin of the onset of neuronal degeneration,” explains Giovanni Marsicano, Inserm research director and co-senior author of the study.

The findings add to a growing body of research examining how metabolism, inflammation, cellular stress, and energy production may influence Alzheimer’s disease from its earliest stages.

Recent studies, including research from Mayo Clinic, have also linked disruptions in mitochondrial energy systems to Alzheimer’s progression and treatment response.

Could this lead to new treatments for dementia?

Researchers caution that the work remains at an early stage and was conducted only in animal models.

Scientists still need to determine whether similar approaches could safely work in humans and whether boosting mitochondrial activity over long periods would remain effective.

Still, researchers believe the findings could help identify entirely new therapeutic targets for dementia.

“These results will need to be extended, but they allow us to better understand the important role of mitochondria in the proper functioning of our brain. Ultimately, the tool we developed could help us identify the molecular and cellular mechanisms responsible for dementia and facilitate the development of effective therapeutic targets,” explains Étienne Hebert Chatelain, professor at the Université de Moncton and co-senior author of the study.

The next step is to investigate whether continuously restoring mitochondrial activity could slow disease progression, delay neuron loss, or even prevent irreversible brain damage.

“Our work now consists of trying to measure the effects of continuous stimulation of mitochondrial activity to see whether it impacts the symptoms of neurodegenerative diseases and, ultimately, delays neuronal loss or even prevents it if mitochondrial activity is restored,” added Luigi Bellocchio, Inserm researcher and co-senior author of the study.

What could this mean for the future of dementia research?

The study highlights a potentially major shift in how scientists think about memory loss and neurodegenerative disease.

Instead of focusing only on damaged or dying brain cells, future therapies may also target living neurons that are struggling to produce enough energy.

For now, the research offers a compelling possibility: by restoring the brain’s energy supply, scientists may one day find new ways to slow, reduce, or perhaps prevent some symptoms of dementia.

(With inputs from ANI)